Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
United-Guardian Inc (UG)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: UG (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 14.22% | Avg. Invested days 40 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 37.46M USD | Price to earnings Ratio 12.94 | 1Y Target Price - |
Price to earnings Ratio 12.94 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.92 | 52 Weeks Range 7.73 - 15.74 | Updated Date 06/29/2025 |
52 Weeks Range 7.73 - 15.74 | Updated Date 06/29/2025 | ||
Dividends yield (FY) 8.59% | Basic EPS (TTM) 0.63 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 25.3% | Operating Margin (TTM) 24.62% |
Management Effectiveness
Return on Assets (TTM) 15.65% | Return on Equity (TTM) 26.24% |
Valuation
Trailing PE 12.94 | Forward PE - | Enterprise Value 29334895 | Price to Sales(TTM) 3.28 |
Enterprise Value 29334895 | Price to Sales(TTM) 3.28 | ||
Enterprise Value to Revenue 2.57 | Enterprise Value to EBITDA 8.81 | Shares Outstanding 4594320 | Shares Floating 2949185 |
Shares Outstanding 4594320 | Shares Floating 2949185 | ||
Percent Insiders 35.81 | Percent Institutions 22.79 |
Upturn AI SWOT
United-Guardian Inc
Company Overview
History and Background
United-Guardian, Inc. was founded in 1942. The company develops, manufactures, and markets personal care products, pharmaceuticals, medical devices, and specialty industrial products. They are known for their COATSOME delivery system and Lubrajel Oil. The company has evolved from a chemical manufacturer to a developer of innovative delivery systems and specialty ingredients.
Core Business Areas
- Personal Care Ingredients: Develops and manufactures ingredients used in cosmetics, toiletries, and other personal care products. Focuses on moisture enhancers, film formers, and delivery systems.
- Pharmaceuticals and Medical Devices: Produces ingredients and formulations for pharmaceutical and medical device applications. Focuses on lubrication, delivery, and biocompatibility.
- Specialty Industrial Products: Develops and manufactures specialty chemicals for industrial applications, including lubricants and surfactants.
Leadership and Structure
Ronald A. Ahrens serves as the President and CEO. The company has a traditional corporate structure with departments focused on research and development, manufacturing, sales, and marketing.
Top Products and Market Share
Key Offerings
- Lubrajel Oil: A water-based lubricant and moisturizing gel used in personal care products, pharmaceuticals, and medical devices. Market share information is not readily available, but it is a key product line. Competitors include Dow, Ashland, and BASF.
- COATSOME: A patented delivery system used to encapsulate and deliver active ingredients in personal care and pharmaceutical formulations. Market share information is not publicly available. Competitors include Evonik, Lipotec, and Seppic.
Market Dynamics
Industry Overview
The specialty chemicals industry is characterized by innovation, regulatory compliance, and increasing demand for sustainable and bio-based ingredients. The personal care and pharmaceutical sectors are key markets.
Positioning
United-Guardian is a niche player focused on specialty ingredients and delivery systems. Their competitive advantages include their patented technologies, long-standing relationships with customers, and focus on high-quality products.
Total Addressable Market (TAM)
The global market for specialty chemicals is estimated to be hundreds of billions of dollars. United-Guardian's TAM is a portion of this, specifically within the personal care, pharmaceutical, and industrial segments. Market reports estimate the personal care ingredients market could be a tens of billions of dollars.
Upturn SWOT Analysis
Strengths
- Patented technologies
- Strong reputation for quality
- Established customer relationships
- Focus on niche markets
Weaknesses
- Small market capitalization
- Limited product diversification
- Dependence on key customers
- Low trading volume
Opportunities
- Expanding into new geographic markets
- Developing new applications for existing technologies
- Acquiring complementary businesses
- Increasing demand for sustainable ingredients
Threats
- Increased competition from larger players
- Changes in regulations
- Economic downturns
- Raw material price fluctuations
Competitors and Market Share
Key Competitors
- DOW
- ASH
- BASF
Competitive Landscape
United-Guardian's competitive advantages include its patented technologies and focus on niche markets. Its disadvantages include its small size and limited product diversification. Larger companies possess more resources and market reach.
Growth Trajectory and Initiatives
Historical Growth: United-Guardian's growth has been modest, driven by organic expansion in its existing markets.
Future Projections: Future growth projections require analyst estimates. Growth is expected to remain incremental.
Recent Initiatives: Recent initiatives may include new product launches, partnerships, or expansions into new markets. Public information is limited.
Summary
United-Guardian is a niche specialty chemical company with a long history and patented technologies, but its small size and limited product diversification create vulnerabilities. The company has a strong financial history and is in a good financial position. They are positioned well in their target market. Regulatory changes could impact the company.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- SEC filings
- Market research reports
- Analyst estimates
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share data is estimated and based on publicly available information, which may be limited.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About United-Guardian Inc
Exchange NASDAQ | Headquaters Hauppauge, NY, United States | ||
IPO Launch date 1992-03-17 | CEO - | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 24 | Website https://u-g.com |
Full time employees 24 | Website https://u-g.com | ||
United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil is incorporated into a Lubrajel base. It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO. In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology. Further, it provides sexual wellness ingredient products, which are hydrogel formulations designed to offer sensory enhancement, lubrication, and moisturization, such as Natrajel NT, Natrajel MA, Natrajel ON, and Natrajel TE product lines. United-Guardian, Inc. was founded in 1942 and is based in Hauppauge, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.